While a SSTR2a is being evaluated as an approach to restoring glucagon counterregulatory failure in rodent models of diabetes (37), other potential effects of acute and chronic SSTR2a administration on glucose metabolism in T2D on are not known. Here, GCG is linked to diabetes mellitus.